Re-Analysis Finds Benefit In Cancer Screening. Should You Believe It?

A striking paper observes that routine blood testing for prostate specific antigen lowered men ’s risk of dying from prostate cancer by 25%-32%.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news